市场调查报告书
商品编码
1466333
泌尿系统器具市场:按产品、适应症、最终用户和应用分类 - 全球预测 2024-2030Urology Devices Market by Product (Dialysis Devices, Laser Systems, Lithotripters), Indication (Benign Prostatic Hyperplasia, Kidney Diseases, Pelvic Organ Prolapse), End-User, Application - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年泌尿系统器械市场规模为406.9亿美元,预计2024年将达到444.1亿美元,2030年将达到755.5亿美元,复合年增长率为9.24%。
泌尿系统器械是用于诊断、监测和治疗泌尿器官系统相关疾病的专用医疗设备和仪器。这些设备包括各种旨在解决影响男性生殖系统(包括肾臟、输尿管、膀胱、尿道和前列腺)的多种泌尿器官系统疾病的产品。此外,随着医疗技术的进步,许多泌尿系统设备融入了微创功能,增加了患者的康復时间并改善了整体治疗结果。多种因素正在推动全球泌尿系统设备市场的成长,例如人口老化、泌尿系统疾病盛行率增加、技术进步以及人们对各种泌尿系统治疗方法的认识不断提高。然而,泌尿系统装置的高成本、产品召回的灾难性发生以及与泌尿系统装置相关的技术限制正在阻碍市场的成长。微创或非侵入性技术的兴起以及客製化、便携性和智慧连接的趋势将推动该领域的大量研究活动和创新,进一步推动市场成长并扩大我们正在创造的市场机会。
主要市场统计 | |
---|---|
基准年[2023] | 406.9亿美元 |
预测年份 [2024] | 444.1亿美元 |
预测年份 [2030] | 755.5亿美元 |
复合年增长率(%) | 9.24% |
产品泌尿系统内视镜的普及可见一斑。
透析机是医疗设备,用于在肾臟无法自然执行这些功能时从血液中去除多余的水、溶质和毒素。此类别包括血液透析机机和腹膜透析设备。血液透析机机包括血液帮浦、透析器和相关监测系统,以确保治疗期间患者的安全。腹膜透析使用导管和患者腹部的腹膜作为膜来交换血液中的液体和溶解物质。透析设备的创新着重于提高患者舒适度、缩短治疗时间并最大限度地减少潜在併发症。泌尿系统雷射系统有多种应用,包括治疗尿路上皮癌、肾结石和良性前列腺增生 (BPH)。这些系统为目标组织提供精确的雷射能量,同时最大限度地减少对周围区域的损害。碾碎是一种用于非侵入性治疗肾结石和胆结石的专用设备。衝击波可用于将结石破碎成更小的碎片,使它们自然地通过或使用微创方法去除。这些设备透过提供手术取石的替代方案彻底改变了泌尿系统治疗。机器人手术系统提供了超越人手能力的精确性、弹性和控制能力,彻底改变了泌尿系统手术。这些系统具有微创手术的优点,包括减少疼痛、减少失血和加速恢復时间。尿动力学系统是评估膀胱、括约肌和尿道功能的诊断设备。它测量尿流率、膀胱内压和残余尿量等变量,以帮助诊断和治疗尿失禁、前列腺增生和神经源性膀胱等疾病。泌尿系统耗材包括导尿管、支架、导管导引线、引流袋等。这些产品对于各种泌尿系统应用至关重要,包括导尿管放置、术后引流和输尿管支架留置。泌尿系统内视镜是泌尿道内各种诊断和治疗手术的必备仪器,例如膀胱镜检查、输尿管镜检查和经尿道前列腺切除术(TURP)。这些仪器具有刚性和弹性,可实现泌尿系统疾病的可视化和治疗。
用于诊断和治疗指定肾臟疾病的泌尿系统装置的需求不断增加
泌尿系统装置如经尿道微波热疗 (TUMT) 装置、雷射系统和经尿道切除术(TURP)套件用于治疗良性前列腺增生 (BPH)。这些装置透过去除或缩小导致阻塞和发炎的多余前列腺组织来帮助缓解泌尿系统症状。植入式前列腺尿道抬高装置等微创治疗越来越普及,因为它们可以有效改善尿流,同时最大限度地减少副作用。对于肾结石、肾癌等肾臟疾病,常用震波碾碎、输尿管镜、经皮肾镜取石术(PCNL)等设备。碎石机有助于非侵入性地将肾结石分解成可接受的大小。医生使用输尿管镜来观察和清除尿路结石并进行切片检查。对于较大或更复杂的结石,PCNL 装置会透过背部的小切口直接从肾臟取出结石。骨盆器官脱垂是指因骨盆底支撑结构减弱而导致骨盆腔器官下降。子宫托是一种标准的泌尿系统装置,用于非手术治疗脱垂,为下降的器官提供结构支撑。手术网片和套件也用于重组手术,以恢復正常的骨盆解剖结构和功能。机器人辅助腹腔镜系统、近距离放射治疗设备和高强度聚焦超音波(HIFU) 设备用于前列腺癌治疗。机器人系统有助于精确地进行前列腺切除手术,具有减少疼痛和加速恢復时间等潜在好处。软性和硬性输尿管镜用于内视镜去除肾结石,并用作主要治疗方法,特别是当结石的尺寸妨碍自然通过时。此外,钬雷射透过提供高效且微创的结石碾碎方法,彻底改变了结石管理。
最终用户:泌尿系统装置在医院和诊所的广泛使用
透析中心是为肾衰竭患者提供维持生命治疗的专业医疗设施。这些中心利用各种泌尿系统设备,旨在当肾臟无法充分执行此功能时过滤血液中的毒素和废物。此环境所使用的设备包括血液透析机机、腹膜透析设备以及透析器和导管等相关消耗品。透析中心需要可靠、高品质的设备来确保治疗的安全性和有效性。医院和诊所是泌尿系统设备的广泛最终用户,涵盖许多医疗机构,从小型门诊诊所到大型三级医院。这些机构的泌尿系统使用泌尿系统设备来诊断、治疗和管理泌尿系统疾病,例如尿失禁、良性前列腺增生、肾结石和尿道感染。此领域使用的主要设备包括导管、内视镜、碎石机和雷射系统。医院和诊所也使用尿液动力学测试设备、泌尿系统手术器械和尿道支架。这些设施优先考虑能够提高患者照护品质、提高业务效率并降低感染风险的设备。
应用越来越多地采用泌尿系统装置来诊断和监测泌尿系统疾病
泌尿系统装置有助于诊断和监测影响泌尿道和男性生殖系统的各种泌尿系统疾病。泌尿系统诊断设备包括膀胱镜、尿动力系统和超音波诊断设备。这些设备可以对膀胱等区域进行目视检查,收集尿流和压力资料,并对泌尿系统结构进行非侵入性成像。患者监护设备追踪泌尿器官系统的重要功能,并随着时间的推移准确评估个人的状况。产生的资料可帮助医疗保健专业人员就患者护理做出明智的决策,从而实现准确的诊断和有效的治疗计划。泌尿系统疾病的治疗由各种旨在满足患者特定需求的设备所支援。这些范围从用于微创手术的内视镜到用于破碎肾结石的体外震波碾碎(ESWL)。导管、支架和泌尿系统雷射为尿路阻塞和前列腺手术提供微创解决方案。此外,机器人手术系统越来越多地用于进行精密泌尿系统手术,改善治疗效果并缩短患者復原时间。
区域洞察
由于先进的医疗基础设施、人们对泌尿系统疾病的认识不断提高以及行业参与者的强大影响力,美洲在全球泌尿系统器械市场中占据重要地位。由于泌尿系统疾病的流行、医疗费用的上涨和有利的报销政策,该区域市场正在经历显着增长。此外,技术创新和微创手术的日益普及正在推动该地区的市场成长。在欧洲地区,老年人口的增加和先进医疗技术的引入正在支撑泌尿系统器械市场。此外,有利的政府措施的实施和重要市场参与者的存在也有助于市场成长。增加对研发活动的投资以及改善医疗设施正在推动欧洲泌尿系统设备市场的成长。在中东和非洲,医疗基础设施的改善、可支配收入的增加以及政府医疗保健现代化措施正在促进市场成长。由于医疗基础设施和支出不断扩大,以及该地区各国对泌尿系统疾病的认识不断提高,亚太地区被认为是泌尿系统设备成长最快的市场。此外,该地区庞大的患者群和不断改善的经济状况预计将为市场成长提供有利的机会。
FPNV定位矩阵
FPNV定位矩阵对于评估泌尿系统器械市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对泌尿系统器材市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争力评估及资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.泌尿系统器械市场的市场规模与预测是多少?
2.泌尿系统器械市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3.泌尿系统器械市场的技术趋势和法规结构是什么?
4.泌尿系统器械市场主要厂商的市场占有率是多少?
5. 进入泌尿系统器械市场的合适型态和策略手段是什么?
[180 Pages Report] The Urology Devices Market size was estimated at USD 40.69 billion in 2023 and expected to reach USD 44.41 billion in 2024, at a CAGR 9.24% to reach USD 75.55 billion by 2030.
Urology devices are specialized medical instruments and apparatus used in diagnosing, monitoring, and treating disorders associated with the urinary system. These devices encompass various products designed to tackle multiple urological conditions that affect the kidneys, ureters, bladder, urethra, and male reproductive organs, including the prostate. Moreover, with advancements in medical technology, many urology devices incorporate minimally invasive features, enhancing patient recovery times and improving overall outcomes. Various factors, including the rise in the aging population, an increased prevalence of urological disorders, technological advancements, and the growing awareness regarding the availability of various urological treatments, propel the global urology devices market growth. However, the high cost of urology devices, the distressing rate of product recalls, and the technical limitations associated with urology devices hamper the market growth. The rise of minimally invasive or non-invasive techniques and the trends of customizability, portability, and smart connectivity have encouraged considerable research activities and innovation in this domain, further propelling the market growth and creating a market opportunity in the forecasted period.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 40.69 billion |
Estimated Year [2024] | USD 44.41 billion |
Forecast Year [2030] | USD 75.55 billion |
CAGR (%) | 9.24% |
Product: Significant penetration of urology endoscopes
Dialysis devices are medical apparatus used to remove excess water, solutes, and toxins from the blood in individuals whose kidneys cannot perform these functions naturally. This category includes hemodialysis and peritoneal dialysis equipment. Hemodialysis devices include blood pumps, dialyzers, and related monitoring systems to ensure patient safety during treatment. Peritoneal dialysis relies on a catheter and uses the peritoneum of the abdomen in the patient as a membrane through which fluids and dissolved substances are exchanged from the blood. The innovation in dialysis devices focuses on enhancing patient comfort, reducing treatment time, and minimizing potential complications. Laser systems in urology serve diverse applications, including treating urothelial carcinomas, kidney stones, and benign prostatic hyperplasia (BPH). These systems deliver precise laser energy to target tissue with minimal damage to surrounding areas. Lithotripters are specialized devices used in non-invasive kidney stones and gallstone treatment. They employ shock waves to break down calculi into smaller pieces that can be excreted naturally or removed with less invasive techniques. These devices have revolutionized urological care by providing an alternative to the surgical removal of stones. Robotic surgical systems have transformed urologic surgery by providing enhanced precision, flexibility, and control beyond the capabilities of the human hand. These systems offer the benefits of minimally invasive surgery, including reduced pain, less blood loss, and quicker recovery times. Urodynamic systems are diagnostic devices used to assess the functioning of the bladder, sphincters, and urethra. They measure variables such as urine flow rate, bladder pressure, and residual urine volume to aid in the diagnosis and management of conditions such as urinary incontinence, BPH, and neurogenic bladder. Urology consumables include catheters, stents, guidewires, and drainage bags. These products are essential for various urological applications comprising urinary catheterization, postoperative drainage, and ureteral stenting. Urology endoscopes are vital instruments for various diagnostic and therapeutic procedures within the urinary tract, such as cystoscopies, ureteroscopies, and transurethral resections of the prostate (TURP). These devices are rigid and flexible, enabling the visualization and treatment of urological conditions.
Indication: Growing need of urology devices to diagnose and treat kidney diseases
In the management of benign prostatic hyperplasia (BPH), urology devices such as transurethral microwave thermotherapy (TUMT) machines, laser systems, and transurethral resection (TURP) kits are used. These devices help alleviate urinary symptoms by removing or reducing excess prostate tissue that causes obstruction and irritation. Minimally invasive treatments, including implantable prostatic urethral lift devices, have become more prevalent due to their effectiveness in improving urinary flow while minimizing side effects. For kidney diseases, including kidney stones and kidney cancer, devices such as shock wave lithotripters, ureteroscopy, and percutaneous nephrolithotomy (PCNL) equipment are commonly used. Lithotripters help in non-invasively breaking down kidney stones into smaller, passable pieces. Ureteroscopes enable physicians to view and remove stones or perform biopsies within the urinary tract. For larger or complex stones, PCNL devices facilitate directly eliminating stones from the kidney through a small incision in the back. Pelvic organ prolapse involves the descent of pelvic organs caused by the weakening of the pelvic floor's supporting structures. Pessaries are standard urology devices utilized for the non-surgical management of prolapse, providing structural support to displaced organs. In reconstructive surgeries, surgical meshes and kits are also used to restore normal pelvic anatomy and function. Prostate cancer treatment involves the use of robotic-assisted laparoscopic systems, brachytherapy devices, and high-intensity focused ultrasound (HIFU) equipment. Robotic systems facilitate precise surgical removal of the prostate gland with potential benefits, including reduced pain and quicker recovery times. Flexible and rigid ureterorenoscopes are used for the endoscopic removal of kidney stones and serve as a primary treatment, especially when the stone size precludes spontaneous passage. Additionally, holmium lasers have revolutionized stone management by providing a highly effective and minimally invasive means of stone fragmentation.
End-User: Extensive use of urology devices by the hospitals & clinics
Dialysis centers are specialized medical facilities that provide life-sustaining treatment for patients with renal failure. These centers utilize various urology equipment designed to filter toxins and waste from the blood when the kidneys cannot perform this function adequately. The devices in these settings include hemodialysis machines, peritoneal dialysis equipment, and associated consumables such as dialyzers and catheters. Dialysis centers require reliable, high-quality devices to ensure the safety and efficacy of their treatment. Hospitals and clinics represent a broad end-user category for urology devices, covering many healthcare settings, from small outpatient clinics to large tertiary care hospitals. Urology departments within these institutions use urology devices to diagnose, treat, and manage urological conditions such as urinary incontinence, benign prostatic hyperplasia, kidney stones, and urinary tract infections. Key devices used in this sector include catheters, endoscopes, lithotripters, and laser systems. Hospitals and clinics may also use urodynamic testing equipment, surgical instruments designed for urological procedures, and urinary stents. These institutions prioritize devices that enhance patient care quality, increase operational efficiency, and reduce the risk of infection.
Application: Proliferating adoption of urology devices for diagnosis & monitoring of urological conditions
Urology devices are instrumental in diagnosing and monitoring various urological conditions affecting the urinary tract and the male reproductive system. Diagnostic urology devices include cystoscopes, urodynamic systems, and ultrasound devices. These tools allow for the visual inspection of areas such as the bladder, the collection of urine flow and pressure data, and the non-invasive imaging of urological structures. Patient monitoring devices track vital urological functions, ensuring accurate assessments of an individual's condition over time. The data obtained assist healthcare professionals in making informed decisions regarding patient care, leading to precise diagnoses and effective treatment plans. The treatment of urological conditions is supported by a wide array of devices designed to address the specific needs of patients. These range from endoscopes used in minimally invasive surgeries to extracorporeal shock wave lithotripsy (ESWL) machines for breaking down kidney stones. Catheters, stents, and urological lasers provide less invasive solutions for urinary obstructions and prostate surgeries. Additionally, robotic surgical systems are increasingly used to perform precise urological surgeries with improved outcomes and shortened patient recovery times.
Regional Insights
The Americas holds a significant position in the global urology devices market, driven by advanced healthcare infrastructure, heightened awareness of urological conditions, and a strong presence of industry players. The regional market experiences significant growth due to the prevalence of urological diseases, increased healthcare expenditure, and favorable reimbursement policies. In addition, technological innovations and the increasing adoption of minimally invasive surgeries are bolstering the market growth in this region. In the European region, the urology devices market is supported by a growing geriatric population and the adoption of advanced healthcare technologies. Additionally, implementing favorable government initiatives and the presence of significant market players contribute to market growth. Increased investment in research and development activities and the improvement in healthcare facilities are facilitating the growth of the urology devices market in Europe. In the Middle East and Africa, factors including improving healthcare infrastructure, rising disposable income, and government initiatives to modernize healthcare contribute to market growth. The Asia-Pacific region is identified as a rapidly growing market for urology devices attributable to the expanding healthcare infrastructure and expenditure and increasing awareness of urological conditions in regional countries. Moreover, the region's large patient pool and improving economic conditions are expected to offer lucrative opportunities for market growth.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Urology Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Urology Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Urology Devices Market, highlighting leading vendors and their innovative profiles. These include Advanced MedTech Holdings Pte. Ltd., Advin Health Care, Allium Medical Solutions Ltd., Ambu A/S, Asahi Kasei Medical Co., Ltd., B. Braun SE, Baxter International Inc., Becton, Dickinson, and Company, BlueWind Medical, Ltd., Boston Scientific Corporation, Cardinal Health, Inc., Coloplast A/S, Cook Group Incorporated, Dialife SA, Dornier MedTech GmbH, Erbe Elektromedizin GmbH, Fresenius SE & Co. KGaA, GE HealthCare Technologies, Inc., Gynesonics, Inc., Hollister Incorporated, Intuitive Surgical, Inc., Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, Laborie Medical Technologies, Inc., McKesson Medical-Surgical Inc., Medline Industries, LP, Medtronic PLC, Nipro Medical Corporation, Olympus Corporation, Precision Optics Corporation, Richard Wolf GmbH, Rockwell Medical Inc., Siemens Healthcare GmbH, SonoMotion, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, and Virtuoso Surgical, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Urology Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Urology Devices Market?
3. What are the technology trends and regulatory frameworks in the Urology Devices Market?
4. What is the market share of the leading vendors in the Urology Devices Market?
5. Which modes and strategic moves are suitable for entering the Urology Devices Market?